{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:12:35Z","timestamp":1793722355180,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102258","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T15:36:23Z","timestamp":1718638583000},"page":"102258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Wenbing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-4836","authenticated-orcid":false,"given":"Zhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102258_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ICU.0000000000000558","article-title":"Retinal neuroprotection: current strategies and future directions","volume":"30","author":"Wubben","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102258_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","article-title":"Neuroprotective strategies for retinal disease","volume":"65","author":"Pardue","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2024.102258_bib3","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms21072262","article-title":"Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead","volume":"21","author":"Boia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-vision-082114-035502","article-title":"Contributions of Retinal Ganglion Cells to Subcortical Visual Processing and Behaviors","volume":"1","author":"Dhande","year":"2015","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib5","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.omtn.2024.102258_bib6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajo.2004.04.058","article-title":"An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma","volume":"138","author":"Friedman","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102258_bib7","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3390\/ijms21072351","article-title":"Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach","volume":"21","author":"Potilinski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-vision-102016-061422","article-title":"Neuroprotection in Glaucoma: Animal Models and Clinical Trials","volume":"3","author":"Almasieh","year":"2017","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib9","first-page":"218","article-title":"Protecting retinal ganglion cells","volume":"31","author":"Khatib","year":"2017","journal-title":"Eye Lond. Engl."},{"key":"10.1016\/j.omtn.2024.102258_bib10","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1167\/iovs.16-19825","article-title":"Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension","volume":"57","author":"Feng","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib11","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","article-title":"Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma","volume":"106","author":"Lambiase","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102258_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2024.102258_bib13","first-page":"283","article-title":"Clinical applications of NGF in ocular diseases","volume":"149","author":"Lambiase","year":"2011","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.omtn.2024.102258_bib14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2174\/1570159X16666180412092859","article-title":"Nerve Growth Factor: Early Studies and Recent Clinical Trials","volume":"16","author":"Rocco","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.omtn.2024.102258_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2006.07.015","article-title":"Point source concentration of GDNF may explain failure of phase II clinical trial","volume":"202","author":"Salvatore","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2024.102258_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nbt0504-521","article-title":"Next-generation protein drugs","volume":"22","author":"Tomlinson","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102258_bib17","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtn.2024.102258_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2016.11.045","article-title":"AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors","volume":"93","author":"Zingg","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2024.102258_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111549","article-title":"Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges","volume":"199","author":"Abulimiti","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.omtn.2024.102258_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102258_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtn.2024.102258_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102258_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2024.102258_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","article-title":"The Biogenesis, Functions, and Challenges of Circular RNAs","volume":"71","author":"Li","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2890","article-title":"Detecting and characterizing circular RNAs","volume":"32","author":"Jeck","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102258_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102258_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","article-title":"Translation of CircRNAs","volume":"66","author":"Pamudurti","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.molcel.2017.05.022","article-title":"Sensing Self and Foreign Circular RNAs by Intron Identity","volume":"67","author":"Chen","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib29","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102258_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2024.102258_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","article-title":"RNA Circularization Diminishes Immunogenicity and Can Extend Translation Duration In\u00a0Vivo","volume":"74","author":"Wesselhoeft","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib32","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100109","article-title":"Lipid Nanoparticles for Drug Delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.omtn.2024.102258_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2024.102258_bib35","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/acsomega.8b00341","article-title":"Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10\u00a0nm for Drug Delivery","volume":"3","author":"Kimura","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.omtn.2024.102258_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2016.03.019","article-title":"Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery","volume":"229","author":"Sato","year":"2016","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2024.102258_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710179","article-title":"Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Injury: Role of Inflammation and Other Factors","volume":"23","author":"Wong","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1523\/JNEUROSCI.09-04-01263.1989","article-title":"Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section","volume":"9","author":"Carmignoto","year":"1989","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2024.102258_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1620\/tjem.187.227","article-title":"Administration of nerve growth factor, brain-derived neurotrophic factor and insulin-like growth factor-II protects phosphate-activated glutaminase in the ischemic and reperfused rat retinas","volume":"187","author":"Tomita","year":"1999","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.omtn.2024.102258_bib40","first-page":"3232","article-title":"Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia","volume":"34","author":"Siliprandi","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","article-title":"Single-Cell Profiles of Retinal Ganglion Cells Differing in Resilience to Injury Reveal Neuroprotective Genes","volume":"104","author":"Tran","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2024.102258_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.expneurol.2015.12.015","article-title":"Reaching the brain: Advances in optic nerve regeneration","volume":"287","author":"Benowitz","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2024.102258_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/nnm-2018-0251","article-title":"Comparative toxicity of PEG and folate-derived blue-emitting silicon nanoparticles: in\u00a0vitro and in\u00a0vivo studies","volume":"14","author":"Calienni","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.omtn.2024.102258_bib44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019souza","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.omtn.2024.102258_bib45","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1167\/iovs.10-5891","article-title":"A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model","volume":"52","author":"Liu","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102258_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.exer.2014.07.021","article-title":"Polyethylene glycol induced mouse model of retinal degeneration","volume":"127","author":"Lyzogubov","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2024.102258_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41590-018-0064-8","article-title":"Innate immune responses to trauma","volume":"19","author":"Huber-Lang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2024.102258_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41420-021-00760-1","article-title":"Retinal ganglion cell loss in an ex\u00a0vivo mouse model of optic nerve cut is prevented by curcumin treatment","volume":"7","author":"Buccarello","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.omtn.2024.102258_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/cells9030677","article-title":"The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific","volume":"9","author":"Yang","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102258_bib50","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","article-title":"Insights into circular RNA biology","volume":"14","author":"Ebbesen","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2024.102258_bib51","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41576-020-0258-4","article-title":"mRNAs, proteins and the emerging principles of gene expression control","volume":"21","author":"Buccitelli","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2024.102258_bib52","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1016\/j.molcel.2021.07.042","article-title":"Structured elements drive extensive circular RNA translation","volume":"81","author":"Chen","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-0270(99)00030-8","article-title":"A submersion method to induce hypoxic damage in organotypic hippocampal cultures","volume":"89","author":"Frantseva","year":"1999","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.omtn.2024.102258_bib54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.molcel.2021.11.019","article-title":"RNA circles with minimized immunogenicity as potent PKR inhibitors","volume":"82","author":"Liu","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib55","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.molcel.2022.03.008","article-title":"Circular RNA migration in agarose gel electrophoresis","volume":"82","author":"Abe","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102258_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.218","article-title":"Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment","volume":"5","author":"Matsumoto","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2024.102258_bib57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41392-023-01710-2","article-title":"Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtn.2024.102258_bib58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","article-title":"Lipid-based nanoparticle formulations for small molecules and RNA drugs","volume":"16","author":"Ickenstein","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.omtn.2024.102258_bib59","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1523\/JNEUROSCI.20-12-04615.2000","article-title":"Lens injury stimulates axon regeneration in the mature rat optic nerve","volume":"20","author":"Leon","year":"2000","journal-title":"J.\u00a0Neurosci."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T03:29:01Z","timestamp":1728358141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162253124001458"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102258","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102258"}}